Osimerinib haematological toxicities in non-small cell lung cancer: a randomised controlled trials meta-analysis

Authors

Institutions

Publication Details

Journal
BMJ Supportive & Palliative Care
Published
2024-08-19
DOI
https://doi.org/10.1136/spcare-2024-005113
Citations
1
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Osimerinib haematological toxicities in non-small cell lung cancer: a randomised controlled trials meta-analysis

Xuehui Jiang, Ting Liu, Yunzhu Shen, Fangfang Xiong et al.
1 citations
BMJ Supportive & Palliative Care
Lung Cancer Treatments and Mutations
0.42
article

Osimerinib haematological toxicities in non-small cell lung cancer: a randomised controlled trials meta-analysis

Xuehui Jiang, Ting Liu, Yunzhu Shen, Fangfang Xiong, Yin Zhang
article en
1 citations

Abstract

No abstract available for this paper.
BMJ Supportive & Palliative CareVol. 14(e2)
Fujian Medical University (CN), Second Affiliated Hospital of Fujian Medical University (CN)
Good health and well-being
Openalex Percentile: Top 34%
Lung Cancer Treatments and Mutations
0.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Osimerinib haematological toxicities in non-small cell lung cancer: a randomised controlled trials meta-analysis — Xuehui Jiang, Ting Liu, et al. · BMJ Supportive & Palliative Care (2024) | TGRS Research Map | TGRS